MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Prepaid expenses andother current assets$6,008K Marketable securities,current$257,902K Cash and cashequivalents$91,253K Other non-currentassets$103K Operating leaseright-of-use assets$1,969K Property and equipment,net$253K Marketable securities,long-term$151,763K Total current assets$355,163K Total assets$509,251K Total liabilities andstockholders equity$509,251K Total stockholdersequity$486,791K Total liabilities$22,460K Accumulated deficit-$159,574K Accumulated othercomprehensive income (loss)$185K Additional paid-in capital$643,201K Operating leaseliability, non-current$1,493K Total currentliabilities$20,967K Common stock, 0.001 parvalue 545,000,000...$48K Series b non-votingconvertible preferred...$2,931K Related party accountspayable and other...$8K Related party commonstock warrant...$9,684K Operating leaseliability, current$419K Accrued expenses andother current...$8,648K Accounts payable$2,208K
Balance Sheet
source: myfinsight.com

Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics, Inc. (ORKA)